Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOpen Orphan Share News (ORPH)

Share Price Information for Open Orphan (ORPH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.45
Bid: 15.30
Ask: 15.60
Change: -0.55 (-3.44%)
Spread: 0.30 (1.96%)
Open: 16.30
High: 15.50
Low: 15.35
Yest. Close: 16.00
ORPH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Open Orphan confirms details around Covid antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan responded to an increase in its share price on Monday morning, as well as media comment over its collaboration with Quotient.

18 May 20 14:11

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

18 May 20 10:51

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

11 May 20 12:03

Open Orphan inks contract with Quotient on Covid-19 antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan's hVIVO subsidiary has entered into an exclusive contract with Quotient to support Covid-19 antibody testing in the UK.

11 May 20 09:06

Open Orphan signs ?3.5m deal with US biotech firm

(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with an unnamed US biotechnology company on Monday, for the provision of a respiratory syncytial virus (RSV) human challenge study.

4 May 20 16:21

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

4 May 20 14:35

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

23 Apr 20 15:40

Open Orphan begins testing of Covid-19 anti-viral treatment

(Sharecast News) - Pharmaceutical services company Open Orphan said it had started testing an anti-viral drug to treat Covid-19 on behalf of its client Nearmedic International.

23 Apr 20 10:21

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

10 Mar 20 14:48

Open Orphan Starts On Coronavirus Challenge Study Model

Open Orphan Starts On Coronavirus Challenge Study Model

9 Mar 20 14:17

Open Orphan agrees study with European biotech firm

(Sharecast News) - Orphan drugs-focussed pharmaceutical company Open Orphan announced the signing of a new contract with an unnamed European biotechnology firm for the provision of an RSV human challenge study.

6 Mar 20 15:23

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Open Orphan Inks New Virus Study Contract With Potential Follow-On

6 Mar 20 11:57

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

27 Feb 20 17:56

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

13 Feb 20 14:45

Open Orphan raising at least ?5m for merger with hVIVO

(Sharecast News) - Pharmaceutical services company Open Orphan announced a fundraising to raise a minimum of £5m before expenses via a conditional placing of new ordinary shares on Friday, at a price of 6.1p each, to institutional and other investors.

31 Jan 20 15:39

Login to your account

Don't have an account? Click here to register.